Kathryn, I have to agree on the need for further validation with the potentially septic patient. As a sepsis coordinator, I am keeping track of the qSOFA score on patients with the potential for sepsis as they are being transferred into either our intermediate care units or critical care units. Not a consistent parameter to date. I, too, would like to do a more formal research study to validate before implementation. Theresa
Theresa Posani, MS, RN, ACNS-BC | Med/Surg CNS/Sepsis Coordinator T 817.250-3907 | M 972.838-7954 [email protected]<mailto:[email protected]> [https://brandcenter.txhealth.org/logos-templates/Logos/Locations%20(Wholly-Owned)/Texas%20Health%20Fort%20Worth/No%20Tagline/RGB-Email%20Signature/THFortWorth-email.jpg] From: Sepsisgroups [mailto:[email protected]] On Behalf Of Martie Mattson Sent: Tuesday, September 27, 2016 12:40 PM To: Reid, Kathryn S. Cc: [email protected] Subject: Re: [Sepsis Groups] SIRS+organ dysfunction vs. qSOFA/SOFA I have some concerns with the using the qSOFA to determine necessity for further screening. Since 2006, I have worked with over 15 hospitals in California and Washington to implement screening, and although I never collected any formal data regarding this, it is my stong impression that in the younger, generally healthier population who get septic, change in mental status and decreased blood pressure are more often later signs. The younger person usually has a greater ability to compensate, so these signs don't show up until later in the septic process and we would miss the opportunity for early recognition that has been proven to reduce mortality. I strongly feel that this tool needs to be validated concurrently in the inpatient and outpatient area clinical area before it is use is recommended as the best tool. Martie Mattson, RN, MSN, CNS Critical Care Consultant and Educator Surviving Sepsis Protocol Implementation [email protected]<mailto:[email protected]> (415) 412-2364 On Thu, Sep 22, 2016 at 10:49 AM, Reid, Kathryn S. <[email protected]<mailto:[email protected]>> wrote: Has anyone developed a successful marriage of the two screenings yet? If so, I would be very interested in how you are using both effectively to capture the core measure population as well as use the new recommendations. Thanks, Katie Katie Swink Reid, MPH, CPHQ Quality Consultant Performance Improvement & Outcomes Inova Loudoun Hospital 44045 Riverside Parkway Leesburg,VA 20176 T 703-858-6367<tel:703-858-6367> | [email protected]<mailto:[email protected]> This communication may contain confidential and/or privileged information. Additionally, this communication may contain protected health information (PHI) that is legally protected from inappropriate disclosure by the Privacy Standards of the Health Insurance Portability and Accountability Act (HIPAA) and relevant Virginia Laws. If you are not the intended recipient, please note that any dissemination, distribution or copying of this communication is strictly prohibited. If you have received this message in error, you should notify the sender immediately by telephone or by return e-mail and delete this message from your computer. Direct questions to the Chief Privacy Officer at 703-205-2337.<https://urldefense.proofpoint.com/v2/url?u=http-3A__www.inova.org_&d=DQMFaQ&c=tAAbe3VWSXg4_eMSItYKuRlnp5vCb2OrQZQHnRXk_fc&r=p79YauGgtjdHZ1G27QaI_5GTY0Yn75iOH6Du_TfKiBc&m=70I_9zk4y3vWW5-JbpLhmxvZGBRe46Palz9v4k9CkQ0&s=IvoQ2DlX86x5rAdkG20QVv_ErrjOFI488EGz8zUz9ZY&e=> <https://urldefense.proofpoint.com/v2/url?u=http-3A__www.inova.org_&d=DQMFaQ&c=tAAbe3VWSXg4_eMSItYKuRlnp5vCb2OrQZQHnRXk_fc&r=p79YauGgtjdHZ1G27QaI_5GTY0Yn75iOH6Du_TfKiBc&m=70I_9zk4y3vWW5-JbpLhmxvZGBRe46Palz9v4k9CkQ0&s=IvoQ2DlX86x5rAdkG20QVv_ErrjOFI488EGz8zUz9ZY&e=> _______________________________________________ Sepsisgroups mailing list [email protected] http://lists.sepsisgroups.org/listinfo.cgi/sepsisgroups-sepsisgroups.org<https://urldefense.proofpoint.com/v2/url?u=http-3A__www.inova.org_&d=DQMFaQ&c=tAAbe3VWSXg4_eMSItYKuRlnp5vCb2OrQZQHnRXk_fc&r=p79YauGgtjdHZ1G27QaI_5GTY0Yn75iOH6Du_TfKiBc&m=70I_9zk4y3vWW5-JbpLhmxvZGBRe46Palz9v4k9CkQ0&s=IvoQ2DlX86x5rAdkG20QVv_ErrjOFI488EGz8zUz9ZY&e=> <https://urldefense.proofpoint.com/v2/url?u=http-3A__www.inova.org_&d=DQMFaQ&c=tAAbe3VWSXg4_eMSItYKuRlnp5vCb2OrQZQHnRXk_fc&r=p79YauGgtjdHZ1G27QaI_5GTY0Yn75iOH6Du_TfKiBc&m=70I_9zk4y3vWW5-JbpLhmxvZGBRe46Palz9v4k9CkQ0&s=IvoQ2DlX86x5rAdkG20QVv_ErrjOFI488EGz8zUz9ZY&e=> The information contained in this message and any attachments is intended only for the use of the individual or entity to which it is addressed, and may contain information that is PRIVILEGED, CONFIDENTIAL, and exempt from disclosure under applicable law. If you are not the intended recipient, you are prohibited from copying, distributing, or using the information. Please contact the sender immediately by return e-mail and delete the original message from your system.
_______________________________________________ Sepsisgroups mailing list [email protected] http://lists.sepsisgroups.org/listinfo.cgi/sepsisgroups-sepsisgroups.org
